Cargando…
Predicting and affecting response to cancer therapy based on pathway-level biomarkers
Identifying robust, patient-specific, and predictive biomarkers presents a major obstacle in precision oncology. To optimize patient-specific therapeutic strategies, here we couple pathway knowledge with large-scale drug sensitivity, RNAi, and CRISPR-Cas9 screening data from 460 cell lines. Pathway...
Autores principales: | Ben-Hamo, Rotem, Jacob Berger, Adi, Gavert, Nancy, Miller, Mendy, Pines, Guy, Oren, Roni, Pikarsky, Eli, Benes, Cyril H., Neuman, Tzahi, Zwang, Yaara, Efroni, Sol, Getz, Gad, Straussman, Ravid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7335104/ https://www.ncbi.nlm.nih.gov/pubmed/32620799 http://dx.doi.org/10.1038/s41467-020-17090-y |
Ejemplares similares
-
Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
por: Ben-Hamo, Rotem, et al.
Publicado: (2011) -
Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies
por: Ben-Hamo, Rotem, et al.
Publicado: (2012) -
The whole-organism heavy chain B cell repertoire from Zebrafish self-organizes into distinct network features
por: Ben-Hamo, Rotem, et al.
Publicado: (2011) -
Correction: Gene expression and network-based analysis reveals a novel role for hsa-miR-9 and drug control over the p38 network in glioblastoma multiforme progression
por: Ben-Hamo, Rotem, et al.
Publicado: (2012) -
MicroRNA-Gene Association As a Prognostic Biomarker in Cancer Exposes Disease Mechanisms
por: Ben-Hamo, Rotem, et al.
Publicado: (2013)